## Core Concept
Amoxicillin+clavulanic acid is a combination antibiotic that pairs a broad-spectrum penicillin (amoxicillin) with a beta-lactamase inhibitor (clavulanic acid). This combination extends the spectrum of amoxicillin to include beta-lactamase-producing bacteria. The mechanism of action involves inhibiting bacterial cell wall synthesis.

## Why the Correct Answer is Right
The combination of amoxicillin and clavulanic acid is effective against a wide range of bacteria, including many strains of *Streptococcus*, *Haemophilus influenzae*, *Escherichia coli*, and *Klebsiella pneumoniae*, among others. Clavulanic acid irreversibly inhibits beta-lactamase enzymes, which many bacteria produce to confer resistance to beta-lactam antibiotics like amoxicillin. However, not all bacteria are susceptible to this combination, particularly those with intrinsic resistance mechanisms or those that produce beta-lactamases that are not inhibited by clavulanic acid.

## Why Each Wrong Option is Incorrect
- **Option A:** *Streptococcus pneumoniae* is generally susceptible to amoxicillin-clavulanate, although resistance rates can vary geographically.
- **Option B:** *Haemophilus influenzae*, including beta-lactamase-producing strains, is susceptible to amoxicillin-clavulanate.
- **Option C:** Many strains of *Escherichia coli* are susceptible, although resistance can occur, especially in certain geographic areas or in specific clinical contexts.

## Why Option D is Correct
- **Option D:** *Pseudomonas aeruginosa* is inherently resistant to amoxicillin-clavulanate. This bacterium produces beta-lactamases that are not effectively inhibited by clavulanic acid, and it also has an impermeable outer membrane and efflux pumps that confer intrinsic resistance to many antibiotics, including amoxicillin-clavulanate.

## Clinical Pearl / High-Yield Fact
A key point to remember is that while amoxicillin-clavulanate is a broad-spectrum antibiotic, it does not cover *Pseudomonas aeruginosa*, a common pathogen in certain infections, especially in immunocompromised patients or those with cystic fibrosis. For *Pseudomonas* coverage, other antibiotics like piperacillin-tazobactam, ceftazidime, or ciprofloxacin may be needed.

## Correct Answer: D. Pseudomonas aeruginosa.